Activated α_IIbβ₃ on platelets mediates flow-dependent NETosis via SLC44A2

Area of Science:

• Immunology
• Hematology
• Thrombosis Research

Background:

• Platelet-neutrophil interactions are crucial for immunity but implicated in thrombotic diseases like deep vein thrombosis (DVT), myocardial infarction, and stroke.
• Understanding the molecular mechanisms of these interactions is key to developing targeted therapies.

Purpose of the Study:

• To elucidate the mechanism of platelet-neutrophil binding and its role in neutrophil extracellular trap (NET) production.
• To investigate the impact of a specific polymorphism in the SLC44A2 gene on platelet-neutrophil interactions and venous thrombosis risk.

Main Methods:

• Studied platelet-neutrophil interactions under flow conditions, focusing on von Willebrand factor (VWF)/glycoprotein Ibα (GPIbα) signaling and integrin α_IIbβ₃ activation.
• Investigated the binding of platelet α_IIbβ₃ to SLC44A2 on neutrophils and its role in mechanosensitive NET production.
• Utilized neutrophils with a specific SLC44A2 polymorphism (rs2288904-A, R154Q) to assess its effect on binding and NET formation.

Main Results:

• Platelet 'priming' via VWF/GPIbα activates integrin α_IIbβ₃, mediating neutrophil and T-cell binding.
• Platelet α_IIbβ₃ binding to neutrophil SLC44A2 triggers mechanosensitive NET production, which is highly prothrombotic.
• The common SLC44A2 polymorphism (rs2288904-A) significantly impairs α_IIbβ₃ and VWF-primed platelet binding to neutrophils, reducing NET formation.

Conclusions:

• Revealed a novel pathway of platelet-neutrophil crosstalk involving mechanosensitive NET production.
• The SLC44A2 R154Q polymorphism offers protection against venous thrombosis by hindering platelet-neutrophil binding and subsequent NET formation.
• Provides mechanistic insight into the protective role of the SLC44A2 rs2288904-A variant in venous thrombosis.